Evaluation of an amikacin loading dose for nosocomial infections in very low birthweight infants

Acta Paediatrica, International Journal of Paediatrics

Volumn 93, Issue 3, 2004, Pages 356-360

  Berger, A ^a,b   Kretzer, V ^a   Gludovatz, P ^a   Heinze, G ^a   Haiden, N ^a   Pollak, A ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Amikacin; Loading dose; Nosocomial infection; Very low birthweight infants

Indexed keywords

AMIKACIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG SCREENING; FEMALE; GESTATIONAL AGE; HEARING; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INFANT; LOW BIRTH WEIGHT; MALE; MEASUREMENT; NEWBORN; PREMATURITY; PRIORITY JOURNAL;

AMIKACIN; ANTI-BACTERIAL AGENTS; CROSS INFECTION; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE;

EID: 1542343870     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250410023809     Document Type: Article

References (15)

1. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy. Importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987; 155: 93-9
2. Mattie H, Craig WA, Pechere JD. Determinants of efficacy and toxicity of aminoglycosides. J Antimicrob Chemother 1998; 24: 281-93
3. Moore RD, Smith CR, Leitman PS. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis 1984; 149: 443-8
4. Miranda JC, Schimmel MM, James LS, Spinelli W, Rosen TS. Gentamicin kinetics in the neonate. Pediatr Pharmacol 1985; 5: 57-62
5. Isemann BT, Kotagal UR, Mashni SM, Luckhaupt EJ, Cythy JJ. Optimal gentamicin therapy in preterm neonates includes loading doses and early monitoring. Ther Drug Monit 1996; 18: 549-55
6. Semchuk W, Shevchuk YM, Sankaran K, Wallace SM. Prospective, randomized, controlled evaluation of a gentamicin loading dose in neonates. Biol Neoate 1995; 67: 13-20
7. Gal P, Ransom JL, Weaver RL. Gentamicin in neonates: the need for loading doses. Am J Perinatol 1990; 7: 254-7
8. Davis A, Bamford J, Wilson I, Ramkalawan T, Forshaw M, Wright S. A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment. Health Technol Assess 1997; 1: 1-176
9. Labaune JM, Bleyzac N, Maire P, Jelliffe RW, Boutroy MJ, Aulagner G, et al. Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models. Biol Neonate 2001; 80: 142-7
10. Petersen P, Wells TG, Kearns GL. Amikacin dosing in neonates: evaluation of a dosing chart based on population pharmacokinetic data. Dev Pharmacol Ther 1991; 16: 203-11
11. Langhendries JP, Battisti O, Bertrand JM, Francois A, Kalenga M, Darimont J, et al. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit. Biol Neonate 1998; 74: 351-62
12. Young TE, Mangum B. Neofax®: a manual of drugs used in neonatal care. 14th ed. North Carolina: Acorn Publishing; 2001
13. Berger A, Kretzer V, Gludovatz P, Rohrmeister K, Prusa AR, Kuhlhauser C. Evaluation of a netilmicin loading dose in very low birthweight infants. Biol Neonate 2003; 83: 25-9
14. Lundergan F, Glasscock GF, Kim EH, Cohen RS. Once-daily gentamicin dosing in newborn infants. Pediatrics 1999; 103: 1228-34
15. Yeung MY, Smyth JP. Targeting gentamicin concentrations in babies. Aust J Hosp Pharm 2000; 30: 98-101